“…In regard to the clinical importance of anti-DP antibodies, we must bear in mind that the relatively lower level of expression of DP molecules on the cell surface has been known from the beginning when DP molecules were still called "SB" [12,13]; and that, because of this lower level of expression, the clinical effect of antigenantibody reactivity is not as striking and prominent as in the case of antibodies specific for antigens in other loci.…”